Over the past several years, pharmaceutical companies have been steadily integrating artificial intelligence (AI) into many aspects of clinical development. Today, AI’s impact is being felt from the ...

Artificial Intelligence (AI) can augment productivity in clinical trial delivery and more, says Piotr Maslak, Director of Operational Data Intelligence at AstraZeneca. Maslak was speaking on the first ...

Clinical trial names span a broad range, from straightforward acronyms to more inspiring titles—see: Eli Lilly’s optimistically dubbed family of Triumph trials—to the downright ostentatious, like ...

Rates and predictors of cancer screening in California (CA) prisons. Association of West African ancestry, reproductive factors, and deprivation with incidence of triple-negative breast cancer among ...

Despite rapid growth, only 9.2% of DCTs are multiregional and over 80% single-country, indicating challenges in international implementation. 2 With regulatory agencies 4–7 underscoring risk-based ...

The clinical trial industry is at a critical juncture where traditional methods are proving insufficient for managing today’s complex studies. AI is rapidly emerging as an essential strategic tool to ...